Crossmark

Synthesis, antiplasmodial activity and in silico molecular docking study of pinocembrin and its analogs

Published Online: 2022-05-24

Published Print: 2022-12

Authors

Melaku, Yadessa

Solomon, Melat

Eswaramoorthy, Rajalakshmanan

Beifuss, Uwe

Ondrus, Vladimir

Mekonnen, Yalemtsehay
Funding

Funding for this research was provided by:

Alexander von Humboldt-Stiftung (3.4-IP-DEU/1074366, 2014-2017, 3.4-IP-DEU/1074366, 2014-2017, 3.4-IP-DEU/1074366, 2014-2017, 3.4-IP-DEU/1074366, 2014-2017, 3.4-IP-DEU/1074366, 2014-2017)
License Information

Text and Data Mining valid from 2022-05-24

Version of Record valid from 2022-05-24
More Information

Article History

Received: 23 February 2022

Accepted: 11 May 2022

First Online: 24 May 2022

Declarations

:

: To conduct this study, ethical clearance was obtained from Institutional Ethics Review Board of College of Natural Sciences, Addis Ababa University (IRB/024/2017). The study is reported in accordance with the Animal Research Reporting of in vivo Experiments (ARRIVE) guidelines (ExternalRef removed) and were handled according to the Guide for the Care and Use of Laboratory Animals (ExternalRef removed).

: Not applicable.

: The authors declare that there is no conflict of interest.

Document is current